Advertisement

Genomic Triplication of the Glycine Decarboxylase Gene and N-Methyl-D-Aspartate Receptor Hypofunction: Improvement by Glycine and D-Cycloserine

  • Kenji Hashimoto
    Correspondence
    Address correspondence to Kenji Hashimoto, Ph.D., Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan.
    Affiliations
    Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 523
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bodkin J.A.
        • Coleman M.J.
        • Godfrey L.J.
        • Carvalho C.M.B.
        • Morgan C.J.
        • Suckow R.F.
        • et al.
        Targeted treatment of individuals with psychosis carrying a copy number variant containing a genomic triplication of the glycine decarboxylase gene.
        Biol Psychiatry. 2019; 86: 523-535
        • Malhotra D.
        • McCathy S.
        • Michaelson J.J.
        • Vacic V.
        • Burdick K.E.
        • Yoon S.
        • et al.
        High frequencies of de novo CNVs in bipolar disorder and schizophrenia.
        Neuron. 2011; 72: 951-963
        • Hashimoto K.
        Targeting of NMDA receptors in new treatments for schizophrenia.
        Expert Opin Ther Targets. 2014; 18: 1049-1063
        • Maekawa M.
        • Ohnishi T.
        • Hashimoto K.
        • Watanabe A.
        • Iwayama Y.
        • Ohba H.
        • et al.
        Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.
        J Neurochem. 2010; 115: 1374-1385
        • Schizophrenia Working Group of the Psychiatric Genomics Consortium
        Biological insights from 108 schizophrenia-associated genetic loci.
        Nature. 2014; 511: 421-427
        • Horio M.
        • Mori H.
        • Hashimoto K.
        Is D-cycloserine a prodrug for D-serine in the brain?.
        Biol Psychiatry. 2013; 73: e33-e34
        • Hashimoto K.
        • Fukushima T.
        • Shimizu E.
        • Komatsu N.
        • Watanabe H.
        • Shinoda N.
        • et al.
        Decreased serum levels of D-serine in patients with schizophrenia: Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
        Arch Gen Psychiatry. 2003; 60: 572-576
        • Hashimoto K.
        • Engberg G.
        • Shimizu E.
        • Nordin C.
        • Lindström L.H.
        • Iyo M.
        Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
        Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29: 767-769
        • Hashimoto K.
        • Engberg G.
        • Shimizu E.
        • Nordin C.
        • Lindström L.H.
        • Iyo M.
        Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
        BMC Psychiatry. 2005; 5: 6
        • Hashimoto K.
        Recent advances in the early intervention in schizophrenia: Future direction from preclinical findings.
        Curr Psychiatry Rep. 2019; 21: 75

      Linked Article